CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
-8.73%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$2.56B
AUM Growth
+$2.56B
(-26%)
Cap. Flow
-$400M
Cap. Flow
% of AUM
-15.58%
Top 10 Holdings %
Top 10 Hldgs %
43.81%
Holding
134
New
13
Increased
7
Reduced
67
Closed
28
Top Buys
| 1 |
Monte Rosa Therapeutics
GLUE
|
$69.6M |
| 2 |
Biomea Fusion
BMEA
|
$48.4M |
| 3 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$47M |
| 4 |
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
|
$44.6M |
| 5 |
VERV
Verve Therapeutics
VERV
|
$40.6M |
Top Sells
| 1 |
C4 Therapeutics
CCCC
|
$80.8M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$64.2M |
| 3 |
Novavax
NVAX
|
$45.3M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$43.6M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$32.8M |
Sector Composition
| 1 | Healthcare | 99.14% |
| 2 | Financials | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
26
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $28.3M | 0.96% |
175,000
-100,000
| -36% | -$16.2M |
|
27
Y-mAbs Therapeutics
YMAB
$390M
| $27M | 0.92% |
800,000
-430,000
| -35% | -$14.5M |
|
|
AGEN
28
Agenus
AGEN
$136M
| $26.4M | 0.9% |
4,807,557
-2,942,443
| -38% | -$16.2M |
|
|
ELEV
29
DELISTED
Elevation Oncology
ELEV
| $25.6M | 0.87% |
+1,983,165
| New | +$25.6M |
|
|
VECT
30
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $25.5M | 0.87% |
+2,226,128
| New | +$25.5M |
|
31
Twist Bioscience
TWST
$1.57B
| $24.7M | 0.84% |
185,000
| – | – |
|
|
RETA
32
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $23.8M | 0.81% |
168,150
-231,850
| -58% | -$32.8M |
|
|
XLRN
33
DELISTED
Acceleron Pharma Inc.
XLRN
| $22M | 0.75% |
175,000
-100,000
| -36% | -$12.5M |
|
34
908 Devices
MASS
$199M
| $21.1M | 0.72% |
545,320
-2
| -0% | -$77 |
|
|
BPMC
35
DELISTED
Blueprint Medicines
BPMC
| $20.9M | 0.71% |
237,546
-9,654
| -4% | -$849K |
|
|
LBPH
36
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $20.9M | 0.71% |
2,321,403
-34,597
| -1% | -$311K |
|
|
IGMS
37
DELISTED
IGM Biosciences
IGMS
| $20.8M | 0.71% |
250,000
-245,769
| -50% | -$20.4M |
|
|
AXNX
38
DELISTED
Axonics, Inc. Common Stock
AXNX
| $20.4M | 0.69% |
322,240
-370,760
| -54% | -$23.5M |
|
39
Praxis Precision Medicines
PRAX
$980M
| $18.7M | 0.64% |
1,024,145
-50,000
| -5% | -$914K |
|
|
DMTK
40
DELISTED
DermTech, Inc. Common Stock
DMTK
| $18.7M | 0.64% |
450,000
-350,000
| -44% | -$14.5M |
|
41
Aligos Therapeutics
ALGS
$75.1M
| $18.5M | 0.63% |
905,467
-361,700
| -29% | -$7.37M |
|
42
Omeros
OMER
$284M
| $17.8M | 0.61% |
1,200,000
-2,100,030
| -64% | -$31.2M |
|
43
Tourmaline Bio
TRML
$645M
| $17.3M | 0.59% |
+1,215,847
| New | +$17.3M |
|
44
Akero Therapeutics
AKRO
$3.65B
| $14.9M | 0.51% |
600,000
-142,549
| -19% | -$3.54M |
|
45
Pliant Therapeutics
PLRX
$105M
| $14M | 0.48% |
482,413
-128,996
| -21% | -$3.76M |
|
46
Cabaletta Bio
CABA
$144M
| $13.9M | 0.47% |
1,611,623
-292,801
| -15% | -$2.52M |
|
47
Pharvaris
PHVS
$1.41B
| $13.6M | 0.46% |
744,863
-119,280
| -14% | -$2.18M |
|
|
48
C4 Therapeutics
CCCC
$182M
| $13.4M | 0.46% |
354,495
-2,135,570
| -86% | -$80.8M |
|
49
Beam Therapeutics
BEAM
$1.9B
| $12.9M | 0.44% |
100,000
-71,775
| -42% | -$9.24M |
|
|
CNTB
50
Connect Biopharma
CNTB
$111M
| $12.7M | 0.43% |
650,000
-350,000
| -35% | -$6.84M |
|